|
antibiotics / Generic Prograf At the internet pharmacy you can buy discreetly shipped prograf tablets and it will cost you considerably less!
New onset post-transplant diabetes mellitus (PTDM) was seen in 20% of Prograf-treated kidney transplant patients. Prograf accomplishes its immune-suppressing effecting by inhibiting an enzyme (calcineurin) crucial for the multiplication of T-cells, cells that are vital to the immune process. The use of oral Prograf allows transplantation specialists to reduce the dose of steroids which are also used to prevent rejection. If you want to know more about this medicine (Prograf) you should consult the product's label.
WarningsImmunosuppressants may affect vaccination. Therefore, during treatment with Prograf, vaccination may be less effective. Lymphoproliferative disorders associated with Epstein-Barr Virus infection have been seen. It has been reported that reduction or discontinuation of immunosuppression may cause the lesions to regress. No evidence of genotoxicity was seen in bacterial (Salmonella and E. coli) or mammalian (Chinese hamster lung-derived cells) in vitro assays of mutagenicity, the in vitro CHO/HGPRT assay of mutagenicity, or in vivo clastogenicity assays performed in mice; tacrolimus did not cause unscheduled DNA synthesis in rodent hepatocytes. Carcinogenicity studies were carried out in male and female rats and mice. Prograf Adverse ReactionsAn increased incidence of malignancy is a recognized complication of immunosuppression in recipients of organ transplants. The most common forms of neoplasms are non-Hodgkin's lymphomas and carcinomas of the skin. As with other immunosuppressive therapies, the risk of malignancies in Prograf recipients may be higher than in the normal, healthy population. There are no adequate and well-controlled studies in pregnant women. Tacrolimus is transferred across the placenta. Hyperglycemia has been noted in many patients; some may require insulin therapy The incidence of adverse events was determined in two randomized comparative liver transplant trials among 514 patients receiving tacrolimus and steroids and 515 patients receiving a cyclosporine-based regimen (CBIR). Endocrine (See Precautions)Based on the poor aqueous solubility and extensive erythrocyte and plasma protein binding, it is anticipated that tacrolimus is not dialyzable to any significant extent; there is no experience with charcoal hemoperfusion. Limited overdosage experience is available. Acute overdosages of up to 30 times the intended dose have been reported. Almost all cases have been asymptomatic and all patients recovered with no sequelae. Occasionally, acute overdosage has been followed by adverse reactions consistent with those listed in the ADVERSE REACTIONS section except in one case where transient urticaria and lethargy were observed. |
0 items for
$0.00
|
